Results

Total Results: 27 records

Showing results for "opiate alkaloids".

21. Durasal–Durezol mix-up illustrates how dangerous product problems persist long after recognition. | PSNet
    psnet.ahrq.gov/issue/durasal-durezol-mix-illustrates-how-dangerous-product-problems-persist-long-after-recognition
    September 21, 2011 - April 4, 2007 Reducing patient harm from opiates.

22. Prevent errors during emergency use of hypertonic sodium chloride solutions. | PSNet
    psnet.ahrq.gov/issue/prevent-errors-during-emergency-use-hypertonic-sodium-chloride-solutions
    March 10, 2021 - April 4, 2007 Reducing patient harm from opiates.

23. ISMP Canada identifies themes associated with fatal medication events in the home. | PSNet
    psnet.ahrq.gov/issue/ismp-canada-identifies-themes-associated-fatal-medication-events-home
    March 15, 2022 - February 27, 2019 Reducing patient harm from opiates.

24. Safety with nebulized medications requires an interdisciplinary team approach. | PSNet
    psnet.ahrq.gov/issue/safety-nebulized-medications-requires-interdisciplinary-team-approach
    November 28, 2018 - September 25, 2013 Reducing patient harm from opiates.

25. FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. | PSNet
    psnet.ahrq.gov/issue/fda-identifies-harm-reported-sudden-discontinuation-opioid-pain-medicines-and-requires-label
    February 17, 2021 - About The Topic Health Care Providers Patients Medicine Ordering/Prescribing Errors Opiates

26. Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death. | PSNet
    psnet.ahrq.gov/issue/codeine-use-certain-children-after-tonsillectomy-andor-adenoidectomy-may-lead-rare-life
    September 01, 2021 - See More About The Topic Children's Hospitals Health Care Providers Pediatric Surgery Opiates

27. FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. | PSNet
    psnet.ahrq.gov/issue/fda-drug-safety-communication-fda-requires-labeling-changes-prescription-opioid-cough-and
    January 25, 2017 - More See More About The Topic Outpatient Pharmacy Pharmacists Pharmacy Opiates